摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-bromo-3-((2-methylallyl)oxy)benzene | 192870-97-6

中文名称
——
中文别名
——
英文名称
1-bromo-3-((2-methylallyl)oxy)benzene
英文别名
1-bromo-3-(2-methylallyloxy)benzene;1-bromo-3-[(2-methylprop-2-en-1-yl)oxy]benzene;1-bromo-3-(2-methyl-allyloxy)-benzene;1-bromo-3-(2-methylprop-2-enoxy)benzene
1-bromo-3-((2-methylallyl)oxy)benzene化学式
CAS
192870-97-6
化学式
C10H11BrO
mdl
MFCD09935291
分子量
227.101
InChiKey
RCVAQVYQEROXRO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    263.3±15.0 °C(Predicted)
  • 密度:
    1.304±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • Benzofuran derivatives
    申请人:Tsukamoto Tetsuya
    公开号:US20100234357A1
    公开(公告)日:2010-09-16
    The present invention provides a compound represented by the following formula (I): wherein: Ring A represents an optionally substituted piperazine ring, an optionally substituted morpholine ring, or an optionally substituted homopiperazine ring; R 1 and R 2 are the same or different from each other, and represent a hydrogen atom or optionally substituted lower alkyl; R 3 and R 4 are the same or different from each other, and represent a hydrogen atom or halogenated or non-halogenated lower alkyl; R 5 to R 7 are the same or different from each other, and represent a hydrogen atom, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, an optionally substituted aromatic heterocyclic ring, optionally substituted amino, or acyl; and represents a single bond or double bond, or a salt thereof.
    本发明提供了一种由以下式(I)表示的化合物: 其中: 环A代表可选择地取代的哌嗪环、可选择地取代的吗啉环或可选择地取代的同环丙二胺环; R1和R2彼此相同或不同,代表氢原子或可选择地取代的较低烷基; R3和R4彼此相同或不同,代表氢原子或卤代或非卤代的较低烷基; R5到R7彼此相同或不同,代表氢原子、羟基、可选择地取代的较低烷基、可选择地取代的较低烯基、可选择地取代的较低烷氧基、可选择地取代的环烷基、可选择地取代的芳基、可选择地取代的芳香杂环、可选择地取代的氨基或酰基;和 代表单键或双键,或其盐。
  • 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as
    申请人:Gruenenthal GmbH
    公开号:US05801201A1
    公开(公告)日:1998-09-01
    1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds, methods of preparing them and the use of these compounds in drugs are described.
    描述了1-苯基-2-二甲基氨甲基环己基-1-醇化合物的制备方法以及这些化合物在药物中的应用。
  • Pd-Catalyzed Intramolecular Oxyalkynylation of Alkenes with Hypervalent Iodine
    作者:Stefano Nicolai、Stéphane Erard、Davinia Fernández González、Jérôme Waser
    DOI:10.1021/ol9027286
    日期:2010.1.15
    chemistry is reported. Both phenol and aromatic or aliphatic acid derivatives could be used under operator-friendly conditions (room temperature, technical solvents, under air). The discovery of the superiority of benziodoxolone-derived hypervalent iodine reagent 3d as an alkyne transfer reagent further expands the rapidly increasing utility of hypervalent iodine reagents in catalysis and is expected
    报道了使用氧化Pd化学的未活化烯烃的分子内氧炔基化的第一个实例。苯酚和芳族或脂肪酸衍生物都可以在操作员友好的条件下使用(室温,工业溶剂,空气中)。苯并恶唑酮衍生的高价碘试剂3d作为炔烃转移试剂的优越性的发现进一步扩展了高价碘试剂在催化中的迅速增长的效用,并有望对其他类似过程产生重要影响。
  • Concise synthesis of functionalized benzocyclobutenones
    作者:P.-H. Chen、Nikolas A. Savage、Guangbin Dong
    DOI:10.1016/j.tet.2014.03.080
    日期:2014.7
    to access functionalized benzocyclobutenones from 3-halophenol derivatives is described. This modified synthesis employs a [2+2] cycloaddition between benzynes generated from dehydrohalogenation of aryl halides using LiTMP and acetaldehyde enolate generated from n-BuLi and THF, followed by oxidation of the benzocyclobutenol intermediates to provide benzocyclobutenones. The [2+2] reaction can be run on
    描述了从 3-卤代苯酚衍生物中获取功能化苯并环丁烯酮的简洁方法。这种改进的合成采用 [2+2] 环加成在芳基卤化物脱卤化氢产生的苄与n- BuLi 和 THF产生的乙醛烯醇化物之间进行 [2+2] 环加成,然后氧化苯并环丁烯醇中间体以提供苯并环丁烯酮。[2+2] 反应可以以 10-g 的规模进行,并提高产率。可以容忍许多官能团,包括烯烃和炔烃。还证明了苄与烯酮甲硅烷基缩醛的偶联得到8-取代的苯并环丁烯酮。
  • BENZOFURAN DERIVATIVES
    申请人:Tsukamoto Tetsuya
    公开号:US20120046277A1
    公开(公告)日:2012-02-23
    The present invention provides a compound represented by the following formula (I): wherein: Ring A represents an optionally substituted piperazine ring, an optionally substituted morpholine ring, or an optionally substituted bromopiperazine ring; R 1 and R 2 are the same or different from each other, and represent a hydrogen atom or optionally substituted lower alkyl; R 3 and R 4 are the same or different from each other, and represent a hydrogen atom or halogenated or non-halogenated lower alkyl; R 3 to R 7 are the same or different from each other, and represent a hydrogen atom, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkoxy, optionally substituted cycloakyl, optionally substituted aryl, an optionally substituted aromatic heterocyclic ring, optionally substituted amino, or acyl; and represents a single bond or double bond, wherein R 2 and R 3 do not exist when carbon atoms respectively adjacent to R 2 : and R 3 form a double bond, and there is no case where all of R 1 to R 7 are hydrogen atoms, and R 1 and R 2 ; may form a ring together with an adjacent carbon atom; or a salt thereof.
    本发明提供了以下式(I)所表示的化合物:其中:环A表示可选取代的哌嗪环、可选取代的吗啡环或可选取代的溴代哌嗪环;R1和R2相同或不同,表示氢原子或可选取代的较低烷基;R3和R4相同或不同,表示氢原子或卤代或非卤代的较低烷基;R3到R7相同或不同,表示氢原子、羟基、可选取代的较低烷基、可选取代的较低烯基、可选取代的较低烷氧基、可选取代的环烷基、可选取代的芳基、可选取代的芳香族杂环环、可选取代的氨基或酰基;表示单键或双键,其中当R2和R3分别相邻的碳原子形成双键时,R2和R3不存在,且不存在R1到R7全为氢原子的情况,R1和R2可以与相邻碳原子共同形成环;或其盐。
查看更多